Shelby Livingston was a healthcare correspondent at Business Insider, reporting on how healthcare is paid for and delivered in the US.
She covered health insurers and healthcare providers, as well as digital-health startups seeking to transform the industry.
Shelby previously covered the health-insurance industry at Modern Healthcare. She won a 2018 Jesse H. Neal Award for her reporting on access to treatment for opioid addiction. She was a finalist for the 2021 NIHCM Awards for her reporting on the evolving roles of community pharmacists.
She received her master's degree in journalism from Northwestern University's Medill School of Journalism after graduating from Clemson University. She lives in Nashville, Tennessee.
Reach out
Got a tip? Reach Shelby securely at shelbylivingston@protonmail.com.
Selected stories
Corporate owners, from UnitedHealth to private-equity firms, are devouring physician practices, making independent doctors a relic of the past.
E-prescription company Surescripts has hired a bank to find potential buyers, including private equity firms.
Walgreens said it's exiting 160 VillageMD primary-care clinics, up from the previously planned 60.
Some One Medical patients in New York could lose in-network access to doctors due to a dispute between Mount Sinai and UnitedHealthcare.
The Change Healthcare cyberattack halted payments to providers. Small mental-health practices are running out of money and at risk of closing.
Umar Afridi launched Foundation Health to help insurers set up their own online pharmacies and pharma companies to sell drugs directly to consumers.
Sarah Jones Simmer, the CEO of weight-loss company Found, is stepping down, a company spokesperson confirmed.
To lower your emergency room bill, understand your insurance plan, look for possible errors, negotiate, and think twice about even going to the ER.
Big retail companies like Walgreens, CVS, and Amazon, want a piece of the $4.5 trillion healthcare industry, but scaling primary care isn't easy.
Former US Surgeon General Jerome Adams said he got a $5,000 bill for a recent ER visit, highlighting big problems with the US healthcare system.
Primary care company VillageMD is shutting down all its clinics in its second-largest market.
Alignment Healthcare and Devoted Health grew Medicare Advantage membership for 2024, but they still haven't captured significant market share.
Wegovy maker Novo Nordisk penalized employers for weight loss drug restrictions. So 2 dropped it.
Ro is the first prominent healthcare company to offer compounded semaglutide. Doctors say the knockoff weight-loss shots can be risky.
Cigna's sale highlights the massive challenges Medicare Advantage insurers are facing, from higher medical costs to lower federal.
A 2020 policy allowed employers to give workers money to buy health coverage on their own. Oscar hopes this will fuel its next growth phase.
Walgreens CEO Tim Wentworth said pharmacies will take part in transparent drug-price models like the one made popular by Mark Cuban.
The insurance startup Devoted Health's valuation remained relatively flat at $12.9 billion, which is viewed as a win in a sparse funding environment.
Patients and doctors want weight-loss shots like Wegovy to be more accessible. But it seems like these drugs will stay out of reach for millions in 2024.
Patients and doctors share their perspectives on the biggest ever revolution in obesity medicine.